SAT0290 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs. non-biologic dmards in ankylosing spondylitis (COMPLETE-AS): 12-month effectiveness data Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bessette, L
  • Khraishi, M
  • Chow, A
  • Pavlova, Viktoria
  • Silverberg, S
  • Stewart, J
  • Remple, V

publication date

  • June 2018